Atai Beckley N V (ATAI)

Nov 25, 2025

H.C. Wainwright Maintains Buy on Atai Beckley (ATAI) Following Breakthrough Therapy and Merger Completion - Insider Monkey

Nov 25, 2025

Nov 24, 2025

AtaiBeckley advances BPL-003 toward Phase 3 After Strong Phase 2 Data topline data i - Proactive financial news

Nov 24, 2025

Nov 19, 2025

Enhanced (ATAI) overhauls leadership, appoints new CEO, executive chairman and CFO - Stock Titan

Nov 19, 2025

Nov 18, 2025

Atai Beckley N.V. (ATAI) Receives Buy Rating on BPL-003 Edge against Spravato - MSN

Nov 18, 2025

Nov 14, 2025

H.C. Wainwright reiterates Buy rating on atai Life Sciences stock By Investing.com - Investing.com Nigeria

Nov 14, 2025

Nov 14, 2025

H.C. Wainwright reiterates Buy rating on atai Life Sciences stock - Investing.com India

Nov 14, 2025

Nov 13, 2025

AtaiBeckley to Participate in the Jefferies Global Healthcare Conference in London - The Manila Times

Nov 13, 2025

Nov 13, 2025

AtaiBeckley (NASDAQ: ATAI) London fireside chat at 11:30 GMT; replay for 90 days - Stock Titan

Nov 13, 2025

Nov 12, 2025

AtaiBeckley advances clinical pipeline, strengthens balance sheet in Q3 - Proactive financial news

Nov 12, 2025

Nov 12, 2025

Atai Beckley Q3 Loss Widens, Revenue Rises; Shares Down Pre-Bell - MarketScreener

Nov 12, 2025

Nov 12, 2025

[8-K] ATAI Life Sciences N.V. Reports Material Event | ATAI SEC FilingForm 8-K - Stock Titan

Nov 12, 2025

Nov 12, 2025

Atai Beckley N.V. Announces Breakthrough Therapy Designation for BPL-003 and Positive Phase 2 Results for Treatment-Resistant Depression - Quiver Quantitative

Nov 12, 2025

Nov 12, 2025

Earnings Flash (ATAI) Atai Beckley N.V. Reports Q3 Revenue $749,000 - MarketScreener

Nov 12, 2025

Nov 12, 2025

Earnings Flash (ATAI) Atai Beckley Posts Q3 Net Loss $0.28 a Share, vs. FactSet Est of $0.11 Loss - MarketScreener

Nov 12, 2025

Nov 12, 2025

AtaiBeckley Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights - The Manila Times

Nov 12, 2025

Nov 12, 2025

AtaiBeckley (NASDAQ: ATAI) closes approx. $150M offering, funding into 2029 - Stock Titan

Nov 12, 2025

Nov 11, 2025

AtaiBeckley’s BPL-003 could redefine psychedelics dosing, analysts believe - Proactive Investors

Nov 11, 2025

Nov 10, 2025

Atai Beckley N.V. (ATAI) Discusses BPL-003 Phase IIb Open-Label Extension Study Results in Treatment Resistant DepressionSlideshow (NASDAQ:ATAI) 2025-11-10 - Seeking Alpha

Nov 10, 2025

Nov 10, 2025

Atai Beckley Reports Positive Phase 2b Extension Data for Depression Treatment - MarketScreener

Nov 10, 2025

Nov 10, 2025

Why Atai Life Sciences N.V. (9VC) stock stays undervalued2025 Earnings Impact & Precise Swing Trade Alerts - newser.com

Nov 10, 2025

Nov 10, 2025

Why Atai Life Sciences N.V. (9VC) stock appears on watchlistsPortfolio Performance Report & Low Drawdown Investment Strategies - newser.com

Nov 10, 2025

Nov 10, 2025

AtaiBeckley Announces Positive Topline Data from the Phase - GlobeNewswire

Nov 10, 2025

Nov 10, 2025

Why Atai Life Sciences N.V. (9VC) stock is trending on social media2025 EndofYear Setup & Intraday High Probability Alerts - newser.com

Nov 10, 2025

Nov 10, 2025

Will Atai Life Sciences N.V. (9VC) stock justify high valuationWeekly Gains Report & Fast Exit Strategy with Risk Control - newser.com

Nov 10, 2025

Nov 10, 2025

Is Atai Life Sciences N.V. stock poised for growth2025 Earnings Impact & Weekly Market Pulse Updates - newser.com

Nov 10, 2025

Nov 10, 2025

AtaiBeckley (NASDAQ: ATAI) Shows Added Effect from Second 12 mg Dose at 8 Weeks - Stock Titan

Nov 10, 2025

Nov 09, 2025

Is Atai Life Sciences N.V. (9VC) stock nearing a technical breakoutJuly 2025 Macro Moves & Daily Growth Stock Tips - newser.com

Nov 09, 2025

Nov 09, 2025

Will Atai Life Sciences N.V. stock reach all time highs in 2025Trade Ideas & Safe Capital Preservation Plans - newser.com

Nov 09, 2025

Nov 08, 2025

ATAI BECKLEY NV Insider Trades - Nasdaq

Nov 08, 2025

Nov 08, 2025

Published on: 2025-11-08 08:57:18 - newser.com

Nov 08, 2025

Nov 08, 2025

Is Atai Life Sciences N.V. (9VC) stock trading at attractive multiplesPortfolio Value Report & Stock Portfolio Risk Control - newser.com

Nov 08, 2025

Nov 07, 2025

ATAI Life Sciences Files Prospectus for Share Resale - MSN

Nov 07, 2025

Nov 07, 2025

[Form 3] ATAI Life Sciences N.V. Initial Statement of Beneficial Ownership - Stock Titan

Nov 07, 2025

Nov 07, 2025

Will Atai Life Sciences N.V. stock sustain high P E ratios2025 Market WrapUp & Fast Momentum Stock Entry Tips - newser.com

Nov 07, 2025

Nov 07, 2025

Atai Beckley N.V.: Target Price Consensus and Analysts Recommendations | ATAI | NL0015000DX5 - MarketScreener

Nov 07, 2025

Nov 07, 2025

Atai Beckley N.V.: Revenue and Earnings Analysts Forecasts Revisions | ATAI | NL0015000DX5 - MarketScreener

Nov 07, 2025

Nov 06, 2025

[Form 4] ATAI Life Sciences N.V. Insider Trading Activity - Stock Titan

Nov 06, 2025

Nov 06, 2025

9VC.SG,0P0001MXOV,0 (9VC.SG) Latest Press Releases & Corporate News - Yahoo! Finance Canada

Nov 06, 2025

Nov 06, 2025

Combining machine learning predictions for Atai Life Sciences N.V.2025 Growth vs Value & Risk Managed Investment Entry Signals - newser.com

Nov 06, 2025

Nov 06, 2025

Building trade automation scripts for Atai Life Sciences N.V.July 2025 Summary & Daily Price Action Insights - newser.com

Nov 06, 2025

Nov 06, 2025

Can Atai Life Sciences N.V. stock resist sector downturnsWeekly Earnings Recap & Expert Approved Trade Ideas - newser.com

Nov 06, 2025

Nov 06, 2025

Why Atai Life Sciences N.V. stock appeals to dividend seekers2025 Top Decliners & Technical Entry and Exit Alerts - newser.com

Nov 06, 2025

Nov 06, 2025

Will Atai Life Sciences N.V. stock benefit from upcoming earnings reportsJuly 2025 Breakouts & Community Driven Trade Alerts - Fundação Cultural do Pará

Nov 06, 2025

Nov 06, 2025

Is Atai Life Sciences N.V. stock a defensive play in 2025Inflation Watch & Real-Time Buy Signal Alerts - newser.com

Nov 06, 2025

Nov 06, 2025

Chart based analysis of Atai Life Sciences N.V. trendsJuly 2025 Chart Watch & Daily Market Momentum Tracking - newser.com

Nov 06, 2025

Nov 06, 2025

Latham & Watkins Advises atai Life Sciences in Strategic Combination With Beckley Psytech to Form AtaiBeckley - Legal Desire Media and Insights

Nov 06, 2025

Nov 06, 2025

Will Atai Life Sciences N.V. (9VC) stock test record highs in 2025Exit Point & AI Driven Price Predictions - newser.com

Nov 06, 2025

Nov 05, 2025

Atai Beckley files prospectus supplement for resale of 5.3 million shares By Investing.com - Investing.com Nigeria

Nov 05, 2025

Nov 05, 2025

Watkins Advises atai Life Sciences in Strategic Combination With Beckley Psytech to Form AtaiBeckley - Latham & Watkins LLP

Nov 05, 2025

Nov 05, 2025

Understanding Atai Life Sciences N.V.’s price movementQuarterly Market Review & Precise Trade Entry Recommendations - newser.com

Nov 05, 2025

Nov 05, 2025

Is Atai Life Sciences N.V. stock recession proofJuly 2025 Update & Accurate Intraday Trade Tips - fcp.pa.gov.br

Nov 05, 2025